DIA401.02+0.04 0.01%
SPX5,525.21+40.44 0.74%
IXIC17,382.94+216.90 1.26%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·04/04/2025 17:06:22
Listen to the news

Gainers

  • Impact BioMedical (AMEX:IBO) stock increased by 73.1% to $0.8 during Friday's regular session. The company's market cap stands at $9.2 million.
  • Regencell Bioscience (NASDAQ:RGC) stock rose 43.62% to $34.9. The market value of their outstanding shares is at $454.1 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 37.05% to $0.52. The company's market cap stands at $1.7 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) shares rose 32.04% to $1.88. The company's market cap stands at $111.6 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 23.95% to $3.57. The market value of their outstanding shares is at $54.3 million.
  • Kairos Pharma (AMEX:KAPA) shares moved upwards by 22.34% to $1.15. The company's market cap stands at $15.7 million.

Losers

  • NeuroOne Medical Tech (NASDAQ:NMTC) stock declined by 44.3% to $0.48 during Friday's regular session. The market value of their outstanding shares is at $14.7 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares fell 32.16% to $1.35. The market value of their outstanding shares is at $1.9 million.
  • Lifecore Biomedical (NASDAQ:LFCR) stock fell 22.62% to $5.27. The company's market cap stands at $195.1 million. As per the press release, Q3 earnings came out yesterday.
  • ProPhase Labs (NASDAQ:PRPH) stock fell 22.2% to $0.27. The company's market cap stands at $8.1 million. As per the news, the Q4 earnings report came out 4 days ago.
  • NewGenIvf Group (NASDAQ:NIVF) stock declined by 22.11% to $0.44. The market value of their outstanding shares is at $2.3 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) shares decreased by 20.6% to $0.26. The market value of their outstanding shares is at $66.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.